What are the differential diagnoses and recommended work‑up for a patient with a one‑month fever, moderate anemia, and lymphocyte‑predominant leukocytosis?

Differential Diagnosis and Work-Up for One-Month Fever with Moderate Anemia and Lymphocytosis

The most critical immediate step is to obtain a peripheral blood smear with manual differential, complete blood count, and comprehensive metabolic panel to distinguish between reactive lymphocytosis (infectious or inflammatory) and hematologic malignancy (chronic lymphocytic leukemia, acute lymphoblastic leukemia, or lymphoma), as these require fundamentally different management pathways. 1

Immediate Diagnostic Priorities

Essential Laboratory Studies

• Peripheral blood smear with manual differential is mandatory because automated analyzers miss critical morphologic features including atypical lymphocytes, blasts, dysplastic changes, and hemophagocytosis that distinguish malignant from reactive processes. 2, 3

• Calculate absolute lymphocyte count from total WBC and differential percentage—do not rely on relative percentages alone, as this leads to missed diagnoses or unnecessary workup. 2

• Complete blood count with differential to assess for concurrent cytopenias (thrombocytopenia, neutropenia) which suggest bone marrow involvement by malignancy or hemophagocytic lymphohistiocytosis (HLH). 3, 4

• Comprehensive metabolic panel including calcium, albumin, creatinine, liver function tests, lactate dehydrogenase (LDH), and uric acid—elevated LDH and uric acid suggest high cellular turnover typical of hematologic malignancies or hemolysis. 2, 3

• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are virtually always elevated in chronic inflammatory conditions, Adult-onset Still's disease, and chronic myelomonocytic leukemia. 2

• Ferritin level—hyperferritinemia (often >500 ng/mL, frequently >10,000 ng/mL) is a cardinal feature of HLH and helps distinguish it from other causes of prolonged fever. 4, 5

• Triglyceride level—hypertriglyceridemia (>265 mg/dL) supports HLH diagnosis. 5

• Fibrinogen level—hypofibrinogenemia (<150 mg/dL) is characteristic of HLH. 5

Lymphocyte Immunophenotyping

• Flow cytometry on peripheral blood with minimum panel of CD3, CD4, CD7, CD8, CD19, CD20, and CD25 to distinguish T-cell from B-cell lymphocytosis and identify clonal populations. 6

• Monoclonal B-cell populations (CD19+/CD20+ with light chain restriction) indicate chronic lymphocytic leukemia (CLL) or other B-cell lymphoproliferative disorders. 6

• Absence of CD19+ B-cells with preserved CD3+ T-cells may reflect B-cell acute lymphoblastic leukemia (B-ALL) in remission after chemotherapy, treatment-related B-cell aplasia, or active B-ALL with circulating blasts replaced by normal T-cells. 7

• CD4+/CD25+ T-cell predominance with HTLV-1 seropositivity defines adult T-cell leukemia/lymphoma (ATL), endemic in Japan, Caribbean, intertropical Africa, Brazil, Eastern Europe, and the Middle East (particularly Iran). 6

Differential Diagnosis by Category

Hematologic Malignancies (Most Critical to Exclude)

• Chronic lymphocytic leukemia (CLL) presents with persistent lymphocytosis (>5000/µL for ≥3 months), often discovered incidentally, with median survival 2–>10 years depending on Binet/Rai stage. 6

• Acute lymphoblastic leukemia (ALL) typically presents with constitutional symptoms, cytopenias, and ≥20% blasts in bone marrow or peripheral blood (lower threshold with specific translocations). 6, 3

• Adult T-cell leukemia/lymphoma (ATL) manifests as acute or lymphoma subtypes with poor prognosis due to multidrug resistance, large tumor burden, hypercalcemia, and profound T-cell immunodeficiency. 6

• Lymphoma (Hodgkin or non-Hodgkin) can present with fever, lymphadenopathy, splenomegaly, and circulating atypical lymphocytes. 8

• Hematological malignancies accounted for 11.5% of prolonged fever diagnoses but caused 58.3% of fever-related fatalities in one prospective series. 8

Infectious Causes

• Epstein-Barr virus (EBV) is the most common infectious trigger of secondary HLH and causes infectious mononucleosis with atypical lymphocytosis. 5

• Coxiella burnetii (Q fever) is a rare but documented cause of HLH, particularly in patients with animal exposure (shepherds, farmers); serological testing is diagnostic. 5

• Salmonella typhi (typhoid fever) causes prolonged fever with relative bradycardia, hepatosplenomegaly, and can trigger secondary HLH with hemophagocytosis, cytopenias, and hyperferritinemia. 4

• Tuberculosis causes monocytosis and lymphocytosis, particularly in endemic areas; obtain interferon-gamma release assay or tuberculin skin test, chest radiograph, and sputum cultures. 2

• HIV, hepatitis C, endocarditis should be considered with recurrent infections or risk factors. 2

• Parasitic infections (malaria, leishmaniasis) cause eosinophilia and monocytosis; travel history to endemic areas is critical. 2

Noninfectious Inflammatory Diseases (Most Prevalent Category)

• Noninfectious inflammatory diseases represented 35.4% of prolonged fever diagnoses in a prospective series, surpassing infections (29.7%), miscellaneous causes (19.8%), and malignancies (15.1%). 8

• Adult-onset Still's disease presents with quotidian fever spikes, salmon-colored evanescent rash, sore throat, arthralgias, hepatosplenomegaly, and monocytosis in 51–87% of cases; ESR and CRP are virtually always elevated. 2

• Systemic lupus erythematosus causes fever, cytopenias, monocytosis, and lymphocytosis with photosensitivity, oral ulcers, and joint pain; obtain ANA, anti-dsDNA, complement levels. 2

• Rheumatoid arthritis can present with extra-articular manifestations including fever and monocytosis. 2

Hemophagocytic Lymphohistiocytosis (HLH)

• HLH diagnostic criteria (≥5 of 8 required): fever, splenomegaly, cytopenias (≥2 lineages: hemoglobin <9 g/dL, platelets <100,000/µL, neutrophils <1000/µL), hypertriglyceridemia (≥265 mg/dL) and/or hypofibrinogenemia (≤150 mg/dL), hemophagocytosis in bone marrow/spleen/lymph nodes, low/absent NK-cell activity, ferritin ≥500 ng/mL, elevated soluble CD25 (IL-2 receptor). 4, 5

• Secondary HLH is precipitated by infections (EBV, Q fever, typhoid, others), malignancies (especially lymphoma), or autoimmune conditions; mortality is extremely high without prompt recognition and treatment. 4, 5

Physical Examination Red Flags

• Splenomegaly is present in 14–65% of chronic myelomonocytic leukemia (CMML) cases and suggests clonal disorder. 2

• Hepatosplenomegaly with fever and cytopenias raises concern for HLH, lymphoma, or leukemia. 4, 5

• Lymphadenopathy is present in 32–74% of CMML cases and in lymphoma. 2

• Cutaneous lesions—salmon-colored evanescent rash suggests Adult-onset Still's disease; vasculitic purpuric rash suggests autoimmune vasculitis. 2

• Weight loss, bruising, fatigue are constitutional symptoms suggestive of hematologic malignancy. 1, 9

Bone Marrow Evaluation Indications

Proceed to bone marrow aspiration and biopsy with cytogenetics when:

• Absolute lymphocyte count ≥1 × 10⁹/L persists for >3 months without identified reactive cause. 2

• Concurrent cytopenias (anemia, thrombocytopenia, neutropenia) suggesting marrow involvement. 2, 3

• Dysplastic features on peripheral smear—pseudo-Pelger-Huët anomaly, hypogranulation, dysgranulopoiesis, promonocytes, or blasts (>1%). 2

• Constitutional symptoms (fever, night sweats, weight loss) with unexplained lymphocytosis. 2

• Suspected HLH—bone marrow examination demonstrates hemophagocytosis (macrophages engulfing erythrocytes, leukocytes, platelets, or their precursors). 4, 5

• Bone marrow studies must include: morphological examination, blast percentage, conventional cytogenetic analysis (cannot be replaced by molecular tests or FISH alone), molecular assays (BCR-ABL, FLT3, NPM1, CEBPA), and Gomori's silver impregnation for fibrosis. 2, 3

Algorithmic Approach

Step 1: Immediate Laboratory Assessment (Day 1)

• CBC with manual differential and peripheral smear
• Comprehensive metabolic panel with LDH and uric acid
• ESR, CRP, ferritin, triglycerides, fibrinogen
• Flow cytometry on peripheral blood (CD3, CD4, CD7, CD8, CD19, CD20, CD25)

Step 2: Interpret Initial Results (Days 1–3)

If blasts or atypical cells present on smear:

• Urgent hematology/oncology referral
• Bone marrow aspiration/biopsy with cytogenetics before any treatment 3

If clonal B-cell population (CD19+/CD20+ with light chain restriction):

• Diagnose CLL; stage with Binet/Rai criteria
• Watch-and-wait if asymptomatic early stage 6

If HLH criteria met (≥5 of 8):

• Initiate HLH-2004 protocol (dexamethasone, etoposide, cyclosporine A, IvIg)
• Search for underlying trigger (EBV serology, Q fever serology, blood cultures, HIV, hepatitis panel) 5

If reactive lymphocytosis (polyclonal, no blasts):

• Proceed to Step 3

Step 3: Targeted Infectious and Inflammatory Work-Up (Days 3–7)

• Travel/exposure history: tuberculosis (interferon-gamma release assay, chest X-ray), parasites (eosinophil count, stool ova/parasites), Q fever (Coxiella burnetii serology if animal exposure)
• Autoimmune screening: ANA, anti-dsDNA, rheumatoid factor, complement (C3, C4) if photosensitivity, oral ulcers, arthralgias
• Infectious serology: EBV (VCA-IgM, VCA-IgG, EBNA), HIV, hepatitis B/C, blood cultures if fever spikes
• HTLV-1 serology if from endemic area (Japan, Caribbean, Africa, Brazil, Iran, Romania) 6

Step 4: Reassess at 3 Weeks

If diagnosis established:

• Treat underlying condition

If no diagnosis and lymphocytosis persists:

• Repeat CBC, peripheral smear, flow cytometry
• Bone marrow aspiration/biopsy with cytogenetics 2

If episodic fever pattern:

• Fever remains obscure in 47.6% of episodic fever cases versus 25.9% of continuous fever cases; consider empiric trial of doxycycline for Q fever or other intracellular pathogens 8, 5

Critical Pitfalls to Avoid

• Do not attribute persistent lymphocytosis to inflammation without excluding infection—tuberculosis, endocarditis, and parasitic infections require specific treatment and can mimic inflammatory conditions. 2

• Do not delay bone marrow evaluation beyond 3 months in unexplained lymphocytosis—CMML and other myeloid neoplasms have poor prognosis; early identification allows consideration of allogeneic stem-cell transplantation. 2

• Do not confuse relative and absolute lymphocytosis—calculate absolute lymphocyte count from total WBC and differential percentage to avoid unnecessary workup or missed diagnoses. 2

• Do not postpone chemotherapy until satisfactory material has been obtained for all diagnostic tests in suspected acute leukemia—but do obtain bone marrow with cytogenetics before starting treatment. 3

• Do not miss HLH—it is frequently fatal without prompt recognition; hyperferritinemia (often >10,000 ng/mL), cytopenias, and hepatosplenomegaly in a febrile patient mandate immediate evaluation. 4, 5

• Do not assume benign etiology in patients with weight loss, bruising, or fatigue—these constitutional symptoms increase suspicion for hematologic malignancy. 1, 9